View:
Mini BasicThis view is available after user registration.
ShortThis view is available when you buy a license.
StandardThis view is available when you buy a license.
CompleteThis view is available when you buy a license.
Doxorubicin 60 / Cyclophosphamide 600 x 4 followed by Paclitaxel 80 / Trastuzumab 2 x 12, Breast Ca, adjuvant, Part B Cycle 2+
Protocol-ID: 492 V1.1 (Mini), AC (DOXO60/CYCL600) x 4 followed by PACL80/TRAS2 x 12, Breast Ca, adj. B C2+Indication(s)
- Breast Cancer (HER2+); ICD-10 C50.-
The publishers and authors assume no liability for the accuracy of the contents. The application is at the own responsibility of the treating physician. ©Onkopti. |
Valid since: 01.04.2020